The cardiac SGLT1 is thought to be activated by various factors, such as insulin, AMP-activated protein kinase (AMPK), persistent hyperglycemia, as well as ischemia–reperfusion injury per se [18–21, 24, 40], all of which can also activate GLUT4. The gene discussed is SLC2A4; the disease is Hyperglycemia.